Bemcentinib and pembrolizumab in patients with relapsed mesothelioma: MIST3, a phase IIa trial with cellular and molecular correlates of efficacy.
- Resource Type
- Article
- Authors
- Krebs, Matthew G; Branson, Amy; Barber, Shaun; Poile, Charlotte; King, Amy; Greystoke, Alastair; Moody, Sam; Nolan, Luke; Scotland, Molly; Darlison, Liz; Bajaj, Amrita; Morgan, Bruno; Brookes, Cassandra; Wells-Jordan, Peter; Richards, Catherine Jane; Thomas, Anne L.; Fennell, Dean Anthony
- Source
- Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p8511-8511, 1p
- Subject
- Language
- ISSN
- 0732183X